Table 1 Association of Bcl2 and c-Met expression with clinicopathological features
From: MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
Variables | No. of cases | No. of expression of Bc12 | No. of expression of c-Met | Bc12 (P) | c-Met (P) | ||
|---|---|---|---|---|---|---|---|
Low = 30 | High = 11 | Low = 29 | High = 12 | ||||
Tumor size (cm) | |||||||
 >4 | 18 | 17 | 1 | 17 | 1 | 0.011 | 0.005 |
 ≤4 | 23 | 13 | 10 | 12 | 11 | ||
Histological grades | |||||||
 Well differentiated | 4 | 4 | 0 | 4 | 0 | 0.056 | 0.06 |
 Moderate differentiated | 34 | 25 | 9 | 24 | 10 | ||
 Poorly differentiated | 3 | 1 | 2 | 1 | 2 | ||
FIGO stage | |||||||
 Ib–IIa | 25 | 24 | 1 | 25 | 0 | 0.000 | 0.000 |
 IIb–IIIa | 12 | 6 | 6 | 4 | 8 | ||
 IIIb above | 4 | 0 | 4 | 0 | 4 | ||
Lymph node metasis | |||||||
 Yes | 17 | 7 | 10 | 7 | 10 | 0.000 | 0.001 |
 No | 24 | 23 | 1 | 22 | 2 | ||